A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer-Reference-Cited by-同舟云学术

A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer

Published:2002-06 Issue:6 Volume:13 Page:874-882
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Sculier J.P.,Lafitte J.J.,Lecomte J.,Berghmans T.,Thiriaux J.,Florin M.C.,Efremidis A.,Alexopoulos C.G.,Recloux P.,Ninane V.,Mommen P.,Paesmans M.,Klastersky J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/13/6/874/587571/mdf154.pdf

Reference28 articles.

1. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;Br Med J,1995

2. Best supportive care or chemotherapy for stage IV non-small-cell lung cancer;Sculier,1999

3. Chemotherapy of non-small-cell bronchial cancers. Meta-analysis of the literature as a function of the extent of the disease;Donnadieu;Rev Mal Respir,1991

4. Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party;Sculier;J Clin Oncol,1994

5. A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861;Klastersky;J Clin Oncol,1990

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of the External Validity of the National Comprehensive Cancer Network and European Society for Medical Oncology Guidelines for Non–Small-Cell Lung Cancer in a Population of Patients Aged 80 Years and Older;Clinical Lung Cancer;2017-09

2. Chemotherapy for advanced non-small cell lung cancer in the elderly population;Cochrane Database of Systematic Reviews;2015-10-20

3. Quality of Life in Patients with NSCLC Receiving Maintenance Therapy;Cancers;2015-05-29

4. A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer;Cancer Management and Research;2014-10

5. Increased Risk of High-Grade Hemorrhage in Cancer Patients Treated with Gemcitabine: A Meta-Analysis of 20 Randomized Controlled Trials;PLoS ONE;2013-09-23